SynchNeuro
PrivateLast Round
Seed
Nov 13, 2025
Est. Valuation
$13M
Total Funding Raised
$3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
SynchNeuro, Inc. is a health technology company developing a non-invasive, brain signal-based platform for real-time cardiometabolic health monitoring.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Medical AI, Sensors
Business Model
B2C
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SynchNeuro Comparables
Compare SynchNeuro with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Transdermal Diagnostics | 78% | |
| Eclypia | 78% | |
| Afon Technology | 77% |
SynchNeuro Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 13, 2025 | ||||
| Accelerator | Oct 20, 2025 | ||||
| Angel | Jun 17, 2025 | ||||
| Accelerator | Jun 5, 2025 |
SynchNeuro Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Plug and Play Tech Center | Accelerator |
| MedTech Innovator | Accelerator |
| American Heart Association Ventures | Accelerator |
| Boomerang Ventures | Seed |
| Overwater Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 2, 2026
Monthly visitors grew 165% MoM, reaching 2.7K.
- Nov 13, 2025
$3M round led by Boomerang Ventures and Overwater Ventures.
SynchNeuro Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SynchNeuro's valuation, stock price, and market status.
Is SynchNeuro a public or private company?
SynchNeuro is a private company.
What is the current stock price of SynchNeuro?
SynchNeuro is a private company, so its shares have no public market price. Caplight tracks SynchNeuro's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SynchNeuro worth (valuation)?
SynchNeuro's valuation is estimated at $13.0M based on funding round data.
Can I buy SynchNeuro stock?
SynchNeuro shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SynchNeuro's last funding round?
SynchNeuro's most recent funding round was Seed on November 13, 2025.
Who are the main investors in SynchNeuro?
Key investors in SynchNeuro include Boomerang Ventures, Overwater Ventures.
Will SynchNeuro IPO soon?
No public IPO plans have been announced for SynchNeuro.
How can I track SynchNeuro secondary market activity?
Caplight tracks bids, offers, and trades in SynchNeuro's shares on secondary markets.